Blog

Should Investors Buy PayPal After Its Recent Earnings Report?

PayPal Holdings (NASDAQ: PYPL) got off to a rough start in 2022, as investors continued their transition away from tech stocks and into value-oriented companies in order to combat rising interest

TheMotleyFool

0

This Tech Stock May Be Criminally Underrated

Collaboration software company Atlassian (NASDAQ: TEAM) crushed its latest earnings report in several categories, but one segment's numbers especially stood out. In this episode of "3 Minute Stocks

TheMotleyFool

0

Will Novavax Stock Ever Hit $300 Again?

On Feb. 8 of last year, shares of the coronavirus vaccine developer Novavax (NASDAQ: NVAX) commanded a price near $319, with the market's fervor for its jab feeding more and more into the hype. Of

TheMotleyFool

0

3 Reasons to Think Very Carefully About Where You'll Retire

Knowing when you'll quit the workforce is a crucial part of retirement planning, but few people give as much attention to where they're going to retire. Yet it's worth thinking about if you haven't

TheMotleyFool

0

Better Buy: Aurora Cannabis vs. Canopy Growth

Two of investors' all-time favorite cannabis companies released quarterly results last week. Canada-based Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) have made investors rich in

TheMotleyFool

0

Got $1,000? Buy These Stocks and Hold for 10+ Years

So far, 2022 has certainly caused its fair share of heart palpitations as market volatility continues. With the S&P 500 down more than 6% at the time of this writing, it may not seem like a great

TheMotleyFool

0

Amgen Snags Another Approval for This Promising Cancer Drug

Late last month, Japan's Ministry of Health, Labour and Welfare (MHLW) approved Amgen's (NASDAQ: AMGN) Lumakras to treat advanced non-small cell lung cancer (NSCLC) adult patients with the KRAS G12C

TheMotleyFool

0

Can the Psychedelic Therapeutics Market Take Over Cannabis?

In this segment from Backstage Pass, recorded on Feb. 4, Motley Fool contributor Rachel Warren speaks with Tim Schlidt, co-founder and partner at psychedelic investment fund Palo Santo, about his

TheMotleyFool

0

Worried About Pfizer's Post-Pandemic Growth? These 14 Words from Pfizer's CEO Should Reassure You.

Pfizer (NYSE: PFE) recently reported billions of dollars in revenue last year thanks to its coronavirus vaccine. And the big pharma company predicts its vaccine and new coronavirus treatment

TheMotleyFool

0

3 Biotech Stocks to Buy in February

Don't think the slump for biotech stocks that began last year will go on forever. Of course, not all biotechs experienced the doldrums in the first place. But many of the stocks that did should be

TheMotleyFool

0

3 Unique Cryptocurrencies That Can Turn $100,000 Into $300,000 by 2024

Over the very long-term, the stock market has been a wealth-building machine that's doubled investors' money, on average, about once a decade. But in recent years, cryptocurrencies have run circles

TheMotleyFool

0

Does Block Have 100% Upside? 3 Reasons This Analyst Might Be Right

JPMorgan analyst Tien-tsin Huang recently gave Block (NYSE: SQ) an "overweight" rating with a price target of $200. Huang says that Block's acquisition of buy now, pay later fintech Afterpay will

TheMotleyFool

0

Should You Buy Affirm Holdings on the Dip?

Shares of Affirm Holdings (NASDAQ: AFRM) recently lost over a fifth of their value overnight after delivering mixed results for its fiscal second quarter ended Dec. 31, 2021. The company's latest

TheMotleyFool

0

How $200 Per Month Could Make You a Stock Market Millionaire

Though the stock market can be intimidating at times, it's one of the best ways to generate wealth. In fact, even if you can only afford to invest a little cash each month, it's possible to

TheMotleyFool

0

How Can Investors Justify Buying Beaten-Down Stocks?

Just because a stock's price has dropped doesn't make it a great buy. In this segment of Backstage Pass recorded on Jan. 28, Fool contributors Toby Bordelon, Jason Hall, and Jon Quast discuss the

TheMotleyFool

0

3 Metaverse Stocks With 195% to 383% Upside, According to Wall Street

There's no shortage of sustained double-digit growth opportunities over the next decade. Cybersecurity, cloud computing, and telehealth are all examples of fast-growing trends that investors can't

TheMotleyFool

0

Before Claiming Social Security Early, Ask Yourself 1 Key Question

You're entitled to your full monthly Social Security benefit based on your personal wage history once you reach full retirement age, or FRA. That age is either 66, 67, or somewhere in between

TheMotleyFool

0

Want $3,000 in Passive Income? Invest $20,000 in These 2 Dow Dividend Kings and Wait 5 Years

According to last week's federal Consumer Price Index report, U.S. inflation is now the highest it has been in 40 years. Inflation of 7.5% means that costs will go up and many businesses will have

TheMotleyFool

0